Orchid Pharma has reported a total income of Rs.95.43 crores during the period ended June 30, 2021, as compared to Rs.120.43 crores for the corresponding period last fiscal. For the period ended March 31, 2021, the total income stood at Rs 130.84 crores.

The company has posted a loss of Rs 30.90 crores for the period ended June 30, 2021, as against a loss of Rs 22.66 crores for the corresponding period last fiscal. The loss for the period ended March 31, 2021, stood at Rs 24.72 crores.

The company has reported EPS of Rs. (7.57) for the period ended June 30, 2021, as compared to Rs. (5.55) for the corresponding period last fiscal. The EPS for the period ended March 31, 2021, stood at Rs (6.06).